What You Should Know:
- According to PwC's 2026 Health Services Deals Outlook, the M&A market is set to regain momentum in both deal value and volume after a cooling period in 2025.
- The report highlights a strategic pivot among private equity investors away from reimbursement-heavy assets toward AI-enabled software and services that drive margin expansion without adding labor. With the IPO window reopening and "mega-funds" returning to offense, the winners in 2026 will be
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
The Healthcare Balancing Act: How AI, RPM, and Predictive Analytics Cut Costs Without Sacrificing Care
Calling healthcare a balancing act is probably not doing it justice: Costs are rising, reimbursements are dwindling, and Medicaid is under the knife, but health organizations are still tasked with providing the highest quality of care to the most people they can without breaking the bank.
Under unprecedented financial strain, providers and payers need to optimize operations and trim the budget wherever they can, but never at the expense of quality patient care. That’s why many are investing
Read More
Tampa General Hospital Partners with Reimagine Care to Launch AI-Enabled Virtual Oncology Support
What You Should Know:
- Tampa General Hospital (TGH) Cancer Institute has partnered with Reimagine Care to integrate an AI-enabled virtual cancer care program into its clinical pathways.
- The collaboration, backed by an investment from TGH Ventures, provides 24/7 symptom monitoring and triage to reduce emergency department visits and administrative burden on oncologists. This move aims to expand capacity and improve patient outcomes across Florida, a state facing 115,000 new
Read More
Ritten Raises $35M to Scale AI-Powered Behavioral Health Platform
What You Should Know:
- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors Threshold Ventures, 8VC, Bienville Capital, and others.
- This investment will support Ritten's expansion across mental health and addiction treatment providers spanning all levels of care.
A Unified Platform Purpose-Built for Behavioral Health
Read More
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Philips Acquires SpectraWAVE to “Double Down” on AI-Powered Coronary Imaging
What You Should Know:
- Philips has agreed to acquire SpectraWAVE, Inc., a move designed to bolster its leadership in image-guided therapy by integrating SpectraWAVE’s AI-powered coronary imaging and physiology assessments into the Philips Azurion platform.
- The acquisition adds critical next-generation capabilities, including DeepOCT (optical coherence tomography) and wire-free Fractional Flow Reserve (FFR), to Philips' existing portfolio.
- The strategic expansion aims to
Read More
Moving Beyond the Worklist: Agentic AI and Radiology’s Next Efficiency Leap
After years of flat or falling payment rates, radiology providers are being asked to do more with less. Medicare cuts continue to squeeze margins, and inflation-driven cost hikes in labor and supplies further strain budgets. At the same time, workforce shortages have left many radiology departments shorthanded and clinicians overextended. Meanwhile, the traditional follow-up worklist-centric model—essentially a growing to-do list of patients needing outreach, navigation, and scheduling—is
Read More
Mount Sinai’s AI Tool “V2P” Predicts Disease Type from Genetic Mutations
What You Should Know:
- Scientists at the Icahn School of Medicine at Mount Sinai have developed a new artificial intelligence tool called V2P (Variant to Phenotype) that identifies not only disease-causing genetic mutations but also predicts the specific diseases they may trigger.
- Published in Nature Communications, this machine learning model improves diagnostic speed and accuracy by linking genetic variants to phenotypic outcomes, moving beyond simple "harmful vs. benign"
Read More
The AI Paradox: Why Some Tools Save Millions While Others Increase Physician Burnout
AI has become everyone’s favourite topic in healthcare. From predicting diseases to creating personalised treatment plans, it’s already changing how hospitals, insurers, and health tech companies work. But behind all the excitement sits one big question: is AI really paying off, or is it just more talk than truth?
Like any other business, healthcare organisations need to see clear financial results before calling AI a success. The real question isn’t just how advanced the technology
Read More
Lunit and Daiichi Sankyo Partner to Accelerate Cancer Biomarker Discovery with AI
What You Should Know:
- Lunit has announced a collaboration with pharmaceutical giant Daiichi Sankyo to integrate its AI-powered Lunit SCOPE digital pathology products into two of Daiichi Sankyo's oncology pipeline programs.
- The partnership will utilize Lunit's SCOPE uIHC and SCOPE IO solutions to analyze pathology slides for quantitative data and immune phenotyping, aiming to discover novel biomarkers and improve patient stratification for clinical trials. This move underscores
Read More
